For organs to develop, grow and regenerate, cells must proliferate. But when that process goes awry, leading to uncontrolled ...

The unexpected discovery may provide scientists with new insights into how cancer develops — and how to combat it.

A new treatment possibility has been confirmed for ischemic cardiovascular disease, which does not have a suitable treatment ...

In a potentially major breakthrough for regenerative medicine, scientists at MIT have developed a way to convert skin cells ...

Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules ...

Neuroblastomas are the most common cancer in infants, with about 700–800 diagnoses per year in the US, according to the American Cancer Society. Some of the most high-risk cases are driven by elevated ...

Combining BET inhibitors and PARP inhibitors might help patients resistant to chemotherapy, the study suggests.

PARP7 is a mono-ADP-ribosyl transferase (mono-ART) which has recently gained attention due to its emerging role as a negative ...

A research team led by Prof. Cao Xiaofeng at the Institute of Genetics and Developmental Biology (IGDB) of the Chinese ...